Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics.

Weber, Brittany; Merola, Joseph F; Husni, M Elaine; Di Carli, Marcelo; Berger, Jeffrey S; Garshick, Michael S

Weber, Brittany; Merola, Joseph F; Husni, M Elaine; Di Carli, Marcelo; Berger, Jeffrey S; Garshick, Michael S.

Afiliação

Weber B; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Merola JF; Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Husni ME; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Di Carli M; Division of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Berger JS; Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, OH, USA.
Garshick MS; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Curr Atheroscler Rep ; 23(11): 67, 2021 09 01.

Article em En | MEDLINE | ID: mdl-34468875

Assuntos

Doenças Cardiovasculares; Psoríase; Doenças Cardiovasculares/epidemiologia; Comorbidade; Humanos; Estudos Prospectivos; Psoríase/tratamento farmacológico; Psoríase/epidemiologia

Palavras-chave

Cardiovascular disease; Dyslipidemia; Inflammation; Psoriasis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Doenças Cardiovasculares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Curr Atheroscler Rep Assunto da revista: ANGIOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google